{"id":15239,"date":"2025-01-16T13:12:43","date_gmt":"2025-01-16T21:12:43","guid":{"rendered":"https:\/\/elixirmedical.com\/?page_id=15239"},"modified":"2025-05-21T06:30:15","modified_gmt":"2025-05-21T13:30:15","slug":"ous","status":"publish","type":"page","link":"https:\/\/elixirmedical.com\/ar\/ous\/","title":{"rendered":"OUS Home"},"content":{"rendered":"\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t
<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

TRANS-
FORMATION<\/font><\/em><\/h1>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Unlocked<\/h1>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

At Elixir we believe that only by harnessing the power of transformation can there be real-world impact. We are re-imagining how radical medical technologies will breathe new life into vascular interventions, reshaping it for decades to come.<\/p>

We are a company developing disruptive platforms to treat coronary and peripheral artery disease.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t

\n\t\t\t
\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t
<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

TRANSFORMATION<\/font><\/em>.<\/h1>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

TRANS-
FORMA-
TION<\/font><\/em>.<\/h1>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Unlocked.<\/h1>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

At Elixir we believe that only by harnessing the power of transformation can there be real world impact. We are re-imagining how radical medical technologies will breathe new life into vascular interventions, reshaping it for decades to come.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

We tackle big problems in vascular medicine.<\/i><\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

We use transformation as a solution to improve health and quality of life for patients. By disrupting the status quo, we are going where others have given up.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\tView More<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t
<\/div>\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

CVDs are leading cause of death\n<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t17.9 million lives each year1<\/sup>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\n\t
<\/div>\n<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

244.1 million <\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\tpeople were living with coronary artery disease2<\/sup>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\n\t
<\/div>\n<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

About 6 million \n<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

patients undergo PCI (Percutaneous Coronary Intervention) every year<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t

\n\t\t\t
\n\t\t\t\t\t
<\/div>\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

$407.3 billion<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

in direct and indirect cost in the United States3<\/sup><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t
\n\t
<\/div>\n<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

805,000 annual heart attacks in US\n<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t200,000 are recurrent3<\/sup>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\n\t
<\/div>\n<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

20% of patients experience an adverse event <\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

within 5 years after PCI procedure4<\/sup><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t

\n\t\t\t\tThese findings establish that the bioadaptor addresses the shortcomings of DES and bioresorbable scaffolds and collectively point to a technology-effectiveness standard not seen before. The finding of plaque changes is very exciting, pointing to a new effect and potential benefit of restoring vessel function.\t\t\t<\/p>\n\t\t\t\t\t\t\t

\n\t\t\t\t\t\t\t\t\t\t\tDR. SHIGERU SAITO<\/cite>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/blockquote>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Our technologies<\/i><\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

DynamX\u00ae<\/sup> coronary bioadaptor<\/a><\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

DynamX bioadaptor is a coronary implant that is uniquely designed to not only restore blood flow, but to also unlock and uncage the vessel, allowing the artery to return to its natural physiology, motion and function while DynamX continues to provide dynamic support.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\tLearn More<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\n\t
<\/div>\n<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

LITHIX\u2122 HERTZ CONTACT LITHOTRIPSY CATHETER<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Our novel intravascular lithotripsy catheter uses Hertz Contact Stress to harness the power of physics and mechanics to fracture calcium. Designed with deliverability, safety and simplicity of use in mind.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\tLearn More<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\n\t
<\/div>\n<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

SITE-SPECIFIC ANTITHROMBOTIC THERAPY<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

We developed the world\u2019s first site-specific antithrombotic therapy using two anticoagulants (rivaroxaban and argatroban) and an antiproliferative mTOR inhibitor, sirolimus. The technology is designed to address challenges associated with percutaneous coronary intervention (PCI), including management of thrombotic and bleeding risk.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\tLearn More<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\n\t
<\/div>\n<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

News<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\n\t
\n\t\t
\n\t
\n\t\t
\n\t\t\t\t
\n\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t
\n\t\t\t\t\t\t\t

"Drug-eluting stents have been a blessing in the field of interventional cardiology. Nevertheless, the permanent cage, which prevents vessel remodeling, is a limitation. I believe that keeping the vessel as natural as possible is a positive feature (of the bioadaptor)."<\/h4>\n\t\t\t\t
\n\t\t
Professor Antonio Colombo, MD<\/h5>\n\t\t\t<\/div>\n\t\t<\/div>\n\t<\/div>\n<\/div>\n
\n\t
\n\t\t
\n\t\t\t\t
\n\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t
\n\t\t\t\t\t\t\t

"The bioadaptor is a revolutionary innovation in percutaneous coronary intervention."<\/h4>\n\t\t\t\t
\n\t\t
Dr. Shigeru Saito<\/h5>\n\t\t\t<\/div>\n\t\t<\/div>\n\t<\/div>\n<\/div>\n
\n\t
\n\t\t
\n\t\t\t\t
\n\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t
\n\t\t\t\t\t\t\t

\u201cWhat sets the bioadaptor apart is that it allows the vessel to move more naturally. I think it does not restrict its natural motion. It is a much more physiologic implant than our traditional stents.\u201d<\/h4>\n\t\t\t\t
\n\t\t
Dr. Mladen Vidovich<\/h5>\n\t\t\t<\/div>\n\t\t<\/div>\n\t<\/div>\n<\/div>\n
\n\t
\n\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t
\n\t\t\t\t\t\t\t

"Although drug-eluting stents (DES) work well for treating coronary artery disease (CAD), they still have limitations even with the latest improvements. It's worth noting that even after five years, more than 20% of patients still experience chest pain or need to return to the hospital, which is a significant number. That's why I'm excited about the bioadaptor technology. It's a new kind of device that's different from traditional stents. This innovative approach can potentially overcome DES's limitations and improve how we treat CAD."<\/h4>\n\t\t\t\t
\n\t\t
Manh-Hung Pham, MD<\/h5>\n\t\t\t<\/div>\n\t\t<\/div>\n\t<\/div>\n<\/div>\n
\n\t
\n\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t
\n\t\t\t\t\t\t\t

"Based on the fact that this device has so many wonderful characteristics and so much positive potential, this is something that every physician should be keen on using in his clinical practice."<\/h4>\n\t\t\t\t
\n\t\t
Stefan Verheye, MD<\/h5>\n\t\t\t<\/div>\n\t\t<\/div>\n\t<\/div>\n<\/div>\n
\n\t
\n\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t
\n\t\t\t\t\t\t\t

"We are grateful to the clinical investigators who ran a world-class randomized controlled trial proving the safety and effectiveness of the DynamX bioadaptor against a leading third-gen DES. The findings of the BIOADAPTOR RCT show the leap-forward in patient care provided by uncaging arteries and continued dynamic vessel support, leading to restoration of motion and function that are critical to improving clinical outcomes for CAD patients."<\/h4>\n\t\t\t\t
\n\t\t
Vinayak Bhat, PhD<\/h5>\n\t\t\t<\/div>\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\t<\/div>\n\t\t
<\/div>\n<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t
<\/div>
\"Drug-eluting stents have been a blessing in the field of interventional cardiology. Nevertheless, the permanent cage, which prevents vessel remodeling, is a limitation. I believe that keeping the vessel as natural as possible is a positive feature (of the bioadaptor).\"<\/div>
Professor Antonio Colombo, MD<\/div><\/div><\/div><\/div>
<\/div>
\u201cThe bioadaptor is a revolutionary innovation in percutaneous coronary intervention.\u201d<\/div>
Dr. Shigeru Saito<\/div><\/div><\/div><\/div>
<\/div>
\u201cWhat sets the bioadaptor apart is that it allows the vessel to move more naturally. I think it does not restrict its natural motion. It is a much more physiologic implant than our traditional stents.\u201d<\/div>
Dr. Mladen Vidovich<\/div><\/div><\/div><\/div>
<\/div>
\u201cAlthough drug-eluting stents (DES) work well for treating coronary artery disease (CAD), they still have limitations even with the latest improvements. It's worth noting that even after five years, more than 20% of patients still experience chest pain or need to return to the hospital, which is a significant number. That's why I'm excited about the bioadaptor technology. It's a new kind of device that's different from traditional stents. This innovative approach can potentially overcome DES's limitations and improve how we treat CAD.\u201d<\/div>
Manh-Hung Pham, MD<\/div><\/div><\/div><\/div>
<\/div>
\u201cBased on the fact that this device has so many wonderful characteristics and so much positive potential, this is something that every physician should be keen on using in his clinical practice.\u201d<\/div>
Stefan Verheye, MD<\/div><\/div><\/div><\/div>
<\/div>
\u201cWe are grateful to the clinical investigators who ran a world-class randomized controlled trial proving the safety and effectiveness of the DynamX bioadaptor against a leading third-gen DES. The findings of the BIOADAPTOR RCT show the leap-forward in patient care provided by uncaging arteries and continued dynamic vessel support, leading to restoration of motion and function that are critical to improving clinical outcomes for CAD patients.\u201d<\/div>
Vinayak Bhat, PhD<\/div><\/div><\/div><\/div>\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\t\t<\/i>\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t
\n\t\t\t\t\t\t\t<\/i>\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t
<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

References<\/h4>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t
  1. https:\/\/www.who.int\/health-topics\/cardiovascular-diseases#tab=tab_1<\/span><\/a><\/li>
  2. https:\/\/professional.heart.org\/
    -\/media\/PHD-Files-2\/Science-News\/2\/2022-Heart-and-Stroke-Stat-Update\/2022-Stat-Update-factsheet-GIobal-Burden-of-Disease.pdf<\/a><\/span><\/li>
  3. https:\/\/www.ahajournals.org\/doi\/epub\/
    10.1161\/CIR.0000000000001123<\/a><\/span><\/li>
  4. https:\/\/www.ahajournals.org\/doi\/full\/
    10.1161\/CIRCINTERVENTIONS.114.002230<\/a><\/span><\/li><\/ol>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
    \n\t\t\t\t
    \n\t\t\t\t\t\t\t\t\t
    1. https:\/\/www.who.int\/health-topics\/cardiovascular-diseases#tab=tab_1<\/span><\/a><\/li>
    2. https:\/\/professional.heart.org\/-\/media\/PHD-Files-2\/Science-News\/2\/2022-Heart-and-Stroke-Stat-Update\/2022-Stat-Update-factsheet-GIobal-Burden-of-Disease.pdf<\/a><\/span><\/li>
    3. https:\/\/www.ahajournals.org\/doi\/epub\/10.1161\/CIR.0000000000001123<\/a><\/span><\/li>
    4. https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/CIRCINTERVENTIONS.114.002230<\/a><\/span><\/li><\/ol>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
      \n\t\t\t\t\t\t
      \n\t\t\t\t\t
      \n\t\t\t
      \n\t\t\t\t\t\t
      \n\t\t\t\t
      \n\t\t\t\t\t\t\t\t\t

      PMN 1708 Rev C<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

      \n\t\t\t\t
      \n\t\t\t\t\t\t\t
      \n\t\t\t
      <\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
      \n\t\t\t\t\t\t
      \n\t\t\t\t\t
      \n\t\t\t
      \n\t\t\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"

      TRANS-FORMATION Unlocked At Elixir we believe that only by harnessing the power of transformation can there be real-world impact. We are re-imagining how radical medical technologies will breathe new life into vascular interventions, reshaping it for decades to come. We are a company developing disruptive platforms to treat coronary and peripheral artery disease. TRANSFORMATION. TRANS-FORMA-TION. […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-15239","page","type-page","status-publish","hentry"],"yoast_head":"\nElixir Medical - Vascular Interventions<\/title>\n<meta name=\"description\" content=\"Elixir Medical is re-imagining how radical medical technologies will breathe new life into vascular intervention.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/elixirmedical.com\/ar\/ous\/\" \/>\n<meta property=\"og:locale\" content=\"ar_AR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Elixir Medical - Vascular Interventions\" \/>\n<meta property=\"og:description\" content=\"Elixir Medical is re-imagining how radical medical technologies will breathe new life into vascular intervention.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/elixirmedical.com\/ar\/ous\/\" \/>\n<meta property=\"og:site_name\" content=\"Elixir Medical\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/elixirmedicalinc\" \/>\n<meta property=\"article:modified_time\" content=\"2025-05-21T13:30:15+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/elixirmedical.com\/wp-content\/uploads\/2023\/09\/Dynamx-Bioadaptor-Main-Image-1024x757.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"757\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u0648\u0642\u062a \u0627\u0644\u0642\u0631\u0627\u0621\u0629 \u0627\u0644\u0645\u064f\u0642\u062f\u0651\u0631\" \/>\n\t<meta name=\"twitter:data1\" content=\"8 \u062f\u0642\u0627\u0626\u0642\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/elixirmedical.com\\\/ar\\\/ous\\\/\",\"url\":\"https:\\\/\\\/elixirmedical.com\\\/ar\\\/ous\\\/\",\"name\":\"Elixir Medical - Vascular Interventions\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/elixirmedical.com\\\/ar\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/elixirmedical.com\\\/ar\\\/ous\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/elixirmedical.com\\\/ar\\\/ous\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/elixirmedical.com\\\/wp-content\\\/uploads\\\/2023\\\/09\\\/Dynamx-Bioadaptor-Main-Image.png\",\"datePublished\":\"2025-01-16T21:12:43+00:00\",\"dateModified\":\"2025-05-21T13:30:15+00:00\",\"description\":\"Elixir Medical is re-imagining how radical medical technologies will breathe new life into vascular intervention.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/elixirmedical.com\\\/ar\\\/ous\\\/#breadcrumb\"},\"inLanguage\":\"ar\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/elixirmedical.com\\\/ar\\\/ous\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ar\",\"@id\":\"https:\\\/\\\/elixirmedical.com\\\/ar\\\/ous\\\/#primaryimage\",\"url\":\"https:\\\/\\\/elixirmedical.com\\\/wp-content\\\/uploads\\\/2023\\\/09\\\/Dynamx-Bioadaptor-Main-Image.png\",\"contentUrl\":\"https:\\\/\\\/elixirmedical.com\\\/wp-content\\\/uploads\\\/2023\\\/09\\\/Dynamx-Bioadaptor-Main-Image.png\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/elixirmedical.com\\\/ar\\\/ous\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/elixirmedical.com\\\/ar\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"OUS Home\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/elixirmedical.com\\\/ar\\\/#website\",\"url\":\"https:\\\/\\\/elixirmedical.com\\\/ar\\\/\",\"name\":\"Elixir Medical\",\"description\":\"Transformation Unlocked\",\"publisher\":{\"@id\":\"https:\\\/\\\/elixirmedical.com\\\/ar\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/elixirmedical.com\\\/ar\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ar\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/elixirmedical.com\\\/ar\\\/#organization\",\"name\":\"Elixir Medical\",\"url\":\"https:\\\/\\\/elixirmedical.com\\\/ar\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ar\",\"@id\":\"https:\\\/\\\/elixirmedical.com\\\/ar\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/elixirmedical.com\\\/wp-content\\\/uploads\\\/2023\\\/09\\\/New-Elixir-Logo.png\",\"contentUrl\":\"https:\\\/\\\/elixirmedical.com\\\/wp-content\\\/uploads\\\/2023\\\/09\\\/New-Elixir-Logo.png\",\"width\":5550,\"height\":1870,\"caption\":\"Elixir Medical\"},\"image\":{\"@id\":\"https:\\\/\\\/elixirmedical.com\\\/ar\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/elixirmedicalinc\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Elixir Medical - Vascular Interventions","description":"Elixir Medical is re-imagining how radical medical technologies will breathe new life into vascular intervention.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/elixirmedical.com\/ar\/ous\/","og_locale":"ar_AR","og_type":"article","og_title":"Elixir Medical - Vascular Interventions","og_description":"Elixir Medical is re-imagining how radical medical technologies will breathe new life into vascular intervention.","og_url":"https:\/\/elixirmedical.com\/ar\/ous\/","og_site_name":"Elixir Medical","article_publisher":"https:\/\/www.facebook.com\/elixirmedicalinc","article_modified_time":"2025-05-21T13:30:15+00:00","og_image":[{"width":1024,"height":757,"url":"https:\/\/elixirmedical.com\/wp-content\/uploads\/2023\/09\/Dynamx-Bioadaptor-Main-Image-1024x757.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_misc":{"\u0648\u0642\u062a \u0627\u0644\u0642\u0631\u0627\u0621\u0629 \u0627\u0644\u0645\u064f\u0642\u062f\u0651\u0631":"8 \u062f\u0642\u0627\u0626\u0642"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/elixirmedical.com\/ar\/ous\/","url":"https:\/\/elixirmedical.com\/ar\/ous\/","name":"Elixir Medical - Vascular Interventions","isPartOf":{"@id":"https:\/\/elixirmedical.com\/ar\/#website"},"primaryImageOfPage":{"@id":"https:\/\/elixirmedical.com\/ar\/ous\/#primaryimage"},"image":{"@id":"https:\/\/elixirmedical.com\/ar\/ous\/#primaryimage"},"thumbnailUrl":"https:\/\/elixirmedical.com\/wp-content\/uploads\/2023\/09\/Dynamx-Bioadaptor-Main-Image.png","datePublished":"2025-01-16T21:12:43+00:00","dateModified":"2025-05-21T13:30:15+00:00","description":"Elixir Medical is re-imagining how radical medical technologies will breathe new life into vascular intervention.","breadcrumb":{"@id":"https:\/\/elixirmedical.com\/ar\/ous\/#breadcrumb"},"inLanguage":"ar","potentialAction":[{"@type":"ReadAction","target":["https:\/\/elixirmedical.com\/ar\/ous\/"]}]},{"@type":"ImageObject","inLanguage":"ar","@id":"https:\/\/elixirmedical.com\/ar\/ous\/#primaryimage","url":"https:\/\/elixirmedical.com\/wp-content\/uploads\/2023\/09\/Dynamx-Bioadaptor-Main-Image.png","contentUrl":"https:\/\/elixirmedical.com\/wp-content\/uploads\/2023\/09\/Dynamx-Bioadaptor-Main-Image.png"},{"@type":"BreadcrumbList","@id":"https:\/\/elixirmedical.com\/ar\/ous\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/elixirmedical.com\/ar\/"},{"@type":"ListItem","position":2,"name":"OUS Home"}]},{"@type":"WebSite","@id":"https:\/\/elixirmedical.com\/ar\/#website","url":"https:\/\/elixirmedical.com\/ar\/","name":"Elixir Medical","description":"Transformation Unlocked","publisher":{"@id":"https:\/\/elixirmedical.com\/ar\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/elixirmedical.com\/ar\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ar"},{"@type":"Organization","@id":"https:\/\/elixirmedical.com\/ar\/#organization","name":"Elixir Medical","url":"https:\/\/elixirmedical.com\/ar\/","logo":{"@type":"ImageObject","inLanguage":"ar","@id":"https:\/\/elixirmedical.com\/ar\/#\/schema\/logo\/image\/","url":"https:\/\/elixirmedical.com\/wp-content\/uploads\/2023\/09\/New-Elixir-Logo.png","contentUrl":"https:\/\/elixirmedical.com\/wp-content\/uploads\/2023\/09\/New-Elixir-Logo.png","width":5550,"height":1870,"caption":"Elixir Medical"},"image":{"@id":"https:\/\/elixirmedical.com\/ar\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/elixirmedicalinc"]}]}},"acf":[],"featured_image_src":null,"featured_image_src_square":null,"_links":{"self":[{"href":"https:\/\/elixirmedical.com\/ar\/wp-json\/wp\/v2\/pages\/15239","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/elixirmedical.com\/ar\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/elixirmedical.com\/ar\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/elixirmedical.com\/ar\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/elixirmedical.com\/ar\/wp-json\/wp\/v2\/comments?post=15239"}],"version-history":[{"count":0,"href":"https:\/\/elixirmedical.com\/ar\/wp-json\/wp\/v2\/pages\/15239\/revisions"}],"wp:attachment":[{"href":"https:\/\/elixirmedical.com\/ar\/wp-json\/wp\/v2\/media?parent=15239"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}